We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NRX Pharmaceuticals Inc | NASDAQ:NRXP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.10 | 3.41% | 3.03 | 1.50 | 3.36 | 3.19 | 2.90 | 2.93 | 361,172 | 05:00:07 |
|
/s/ Stephen Willard
Stephen Willard,
Acting Corporate Secretary |
| | | |
|
/s/ Jonathan C. Javitt
Jonathan C. Javitt, MD,
MPH, Chairman Wilmington, Delaware March 11, 2024 |
| | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 7 | | | |
| | | | 9 | | | |
| | | | 18 | | | |
| | | | 18 | | | |
| | | | 18 | | | |
| | | | 19 | | | |
| | | | A-1 | | |
Name of Beneficial Owners
|
| |
Amount
and Nature of Beneficial Ownership |
| |
Percent of
Class |
| ||||||
Directors and Named Executive Officers | | | | | | | | | | | | | |
Stephen H. Willard(1)
|
| | | | 1,050,000 | | | | | | 1.12% | | |
Riccardo Panicucci(2)
|
| | | | 120,667 | | | | | | * | | |
Seth Van Voorhees(3)
|
| | | | 208,837 | | | | | | * | | |
Michael Kunz(4)
|
| | | | 97,680 | | | | | | * | | |
Patrick J. Flynn(5)
|
| | | | 1,639,397 | | | | | | 1.75% | | |
Janet Rehnquist
|
| | | | — | | | | | | — | | |
Chaim Hurvitz(6)
|
| | | | 2,381,298 | | | | | | 2.57% | | |
Jonathan Javitt(7)
|
| | | | 14,768,329 | | | | | | 15.98% | | |
All Executive Officers and Directors as a Group (8 persons)
|
| | | | 19,976,358 | | | | | | 21.06% | | |
All Greater than 5% Holders | | | | | | | | | | | | | |
Glytech, LLC(8)
|
| | | | 9,643,234 | | | | | | 10.43% | | |
| |
THE BOARD RECOMMENDS THAT YOU VOTE “FOR” THE APPROVAL OF THE
REVERSE STOCK SPLIT PROPOSAL, AND PROXIES SOLICITED BY THE BOARD WILL BE VOTED IN FAVOR OF THE PROPOSAL UNLESS A STOCKHOLDER INDICATES OTHERWISE ON THE PROXY. |
| |
| | | | NRX PHARMACEUTICALS, INC. | | ||||||
| | | | By: | | |
|
| |||
| | | | | | | Name: | | | ||
| | | | | | | Title: | | |
1 Year NRX Pharmaceuticals Chart |
1 Month NRX Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions